These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9054740)

  • 1. Lipoprotein oxidation and progression of carotid atherosclerosis.
    Salonen JT; Nyyssönen K; Salonen R; Porkkala-Sarataho E; Tuomainen TP; Diczfalusy U; Björkhem I
    Circulation; 1997 Feb; 95(4):840-5. PubMed ID: 9054740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
    Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
    Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland.
    Salonen R; Seppänen K; Rauramaa R; Salonen JT
    Arteriosclerosis; 1988; 8(6):788-92. PubMed ID: 3196222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.
    Salonen R; Nyssönen K; Porkkala-Sarataho E; Salonen JT
    Am J Cardiol; 1995 Sep; 76(9):34C-39C. PubMed ID: 7572684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension.
    Homer D; Ingall TJ; Baker HL; O'Fallon WM; Kottke BA; Whisnant JP
    Mayo Clin Proc; 1991 Mar; 66(3):259-67. PubMed ID: 2002684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apo-lipoprotein profile in subjects with extracranial carotid atherosclerosis.
    Barbagallo CM; Averna MR; Novo S; Cavera G; Noto D; Liquori M; Spano L; Notarbartolo A
    Int Angiol; 1994 Sep; 13(3):223-8. PubMed ID: 7822898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
    Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content.
    Grønholdt ML; Nordestgaard BG; Wiebe BM; Wilhjelm JE; Sillesen H
    Circulation; 1998 Jan 6-13; 97(1):34-40. PubMed ID: 9443429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
    Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly.
    Kawamoto R; Oka Y; Tomita H; Kodama A
    J Atheroscler Thromb; 2005; 12(3):143-8. PubMed ID: 16020914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC Investigators. Atherosclerosis Risk in Communities Study.
    Råstam L; Lindberg G; Folsom AR; Burke GL; Nilsson-Ehle P; Lundblad A
    Int J Epidemiol; 1996 Oct; 25(5):953-8. PubMed ID: 8921480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
    Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis.
    Salonen JT; Salonen R
    Int J Epidemiol; 1990 Dec; 19(4):911-7. PubMed ID: 2084021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis.
    Tamada M; Makita S; Abiko A; Naganuma Y; Nagai M; Nakamura M
    Metabolism; 2010 May; 59(5):653-7. PubMed ID: 19913853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Egger G; Poewe W; Oberhollenzer F
    Circulation; 1997 Nov; 96(10):3300-7. PubMed ID: 9396420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Amor AJ; Catalan M; Pérez A; Herreras Z; Pinyol M; Sala-Vila A; Cofán M; Gilabert R; Ros E; Ortega E
    Atherosclerosis; 2016 Apr; 247():161-9. PubMed ID: 26921744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis.
    Andrews B; Burnand K; Paganga G; Browse N; Rice-Evans C; Sommerville K; Leake D; Taub N
    Atherosclerosis; 1995 Jan; 112(1):77-84. PubMed ID: 7772070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.
    Salonen JT; Salonen R; Seppänen K; Kantola M; Suntioinen S; Korpela H
    BMJ; 1991 Mar; 302(6779):756-60. PubMed ID: 2021765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study.
    Salonen R; Salonen JT
    Atherosclerosis; 1990 Feb; 81(1):33-40. PubMed ID: 2407252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.